Lumenis, which sells laser-based systems used in surgical, ophthalmic and aesthetic procedures, raised $75 million by offering 6.3 million shares at $12, well below the range of $15 to $17. Lumenis will list on the NASDAQ under the symbol LMNS. Goldman Sachs, Credit Suisse and Jefferies acted as joint bookrunners on the deal.
